Latest news
Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics? - The Motley FoolThe Motley Fool · Sat, 08 Aug 2026 20:30:00 GMTGilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026 - StocktwitsStocktwits · Thu, 06 Aug 2026 00:38:43 GMTGLP-1 Q2 earnings reinforce Lilly's lead over Novo - eMarketereMarketer · Wed, 05 Aug 2026 20:05:40 GMTWeight-loss drug boom widens Lilly’s lead over Novo | 2026-08-05 | Investing News - StockhouseStockhouse · Wed, 05 Aug 2026 19:27:32 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTEli Lilly Is Leading the Pharmaceutical Segment, CEO Says -- Market Talk - BitgetBitget · Wed, 05 Aug 2026 17:50:00 GMTLilly's Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:55:03 GMTEli Lilly pulls further ahead of Novo Nordisk in the red-hot GLP-1 market - medwatch.commedwatch.com · Wed, 05 Aug 2026 13:08:53 GMT